Combined interferon and lamivudine therapy : Is this the treatment of choice for patients with chronic hepatitis B virus infection?TERRAULT, N. A.Hepatology (Baltimore, Md.). 2000, Vol 32, Num 3, pp 675-677, issn 0270-9139Article

Management of hepatitis C in liver transplant recipientsKUO, A; TERRAULT, N. A.American journal of transplantation (Print). 2006, Vol 6, Num 3, pp 449-458, issn 1600-6135, 10 p.Article

Patient, Center and Geographic Characteristics of Nationally Placed LiversLAI, J. C; ROBERTS, J. P; VITTINGHOFF, E et al.American journal of transplantation (Print). 2012, Vol 12, Num 4, pp 947-953, issn 1600-6135, 7 p.Article

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant RecipientsCOFFIN, C. S; STOCK, P. G; TERRAULT, N. A et al.American journal of transplantation (Print). 2010, Vol 10, Num 5, pp 1268-1275, issn 1600-6135, 8 p.Article

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulinTERRAULT, N. A; ZHOU, S; COMBS, C et al.Hepatology (Baltimore, Md.). 1996, Vol 24, Num 6, pp 1327-1333, issn 0270-9139Article

Gender Differences in Liver Donor Quality Are Predictive of Graft LossLAI, J. C; FENG, S; ROBERTS, J. P et al.American journal of transplantation (Print). 2011, Vol 11, Num 2, pp 296-302, issn 1600-6135, 7 p.Article

Hepatitis C virus : Quantitation and distribution in liverTERRAULT, N. A; DAILEY, P. J; FERRELL, L et al.Journal of medical virology. 1997, Vol 51, Num 3, pp 217-224, issn 0146-6615Article

Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantationPESSOA, M. G; TERRAULT, N. A; ROBERTS, J. P et al.Hepatology (Baltimore, Md.). 1997, Vol 25, Num 5, pp 1266-1270, issn 0270-9139Article

Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseGORDON, S. C; HAMZEH, F. M; POCKROS, P. J et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 7, pp 784-793, issn 0269-2813, 10 p.Article

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulinTERRAULT, N. A; SHUAN ZHOU; MCCORY, R. W et al.Hepatology (Baltimore, Md.). 1998, Vol 28, Num 2, pp 555-561, issn 0270-9139Article

Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantationBERENGUER, M; TERRAULT, N. A; WRIGHT, T. L et al.Gastroenterology (New York, NY. 1943). 1996, Vol 111, Num 6, pp 1569-1575, issn 0016-5085Article

Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosisSAXENA, V; MANOS, M. M; TERRAULT, N. A et al.Alimentary pharmacology & therapeutics. 2014, Vol 39, Num 10, pp 1213-1224, issn 0269-2813, 12 p.Article

Height Contributes to the Gender Difference in Wait-List Mortality Under the MELD-Based Liver Allocation SystemLAI, J. C; TERRAULT, N. A; VITTINGHOFF, E et al.American journal of transplantation (Print). 2010, Vol 10, Num 12, pp 2658-2664, issn 1600-6135, 7 p.Article

HIV-Infected Liver and Kidney Transplant Recipients: 1-and 3-Year OutcomesROLAND, M. E; BARIN, B; MURPHY, B et al.American journal of transplantation (Print). 2008, Vol 8, Num 2, pp 355-365, issn 1600-6135, 11 p.Article

Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2) : Is it a marker for immunity?HASSOBA, H. M; TERRAULT, N. A; EL-GOHARY, A. M et al.Journal of medical virology. 1997, Vol 53, Num 4, pp 354-360, issn 0146-6615Article

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection : Relationship to genotype and level of viremiaZHOU, S; TERRAULT, N. A; FERRELL, L et al.Hepatology (Baltimore, Md.). 1996, Vol 24, Num 5, pp 1041-1046, issn 0270-9139Article

Frailty Predicts Waitlist Mortality in Liver Transplant CandidatesLAI, J. C; FENG, S; TERRAULT, N. A et al.American journal of transplantation (Print). 2014, Vol 14, Num 8, pp 1870-1879, issn 1600-6135, 10 p.Article

Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver TransplantationSHAKED, A; GHOBRIAL, R. M; MERION, R. M et al.American journal of transplantation (Print). 2009, Vol 9, Num 2, pp 301-308, issn 1600-6135, 8 p.Article

Antienvelope antibodies are protective against GBV-C reinfection : Evidence from the liver transplant modelHASSOBA, H. M; PESSOA, M. G; TERRAULT, N. A et al.Journal of medical virology. 1998, Vol 56, Num 3, pp 253-258, issn 0146-6615Article

Quantitation of hepatitis G and C viruses in the liver : Evidence that hepatitis G virus is not hepatotropicPESSOA, M. G; TERRAULT, N. A; DETMER, J et al.Hepatology (Baltimore, Md.). 1998, Vol 27, Num 3, pp 877-880, issn 0270-9139Article

Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposisODZE, R. D; QUINN, P. S; TERRAULT, N. A et al.Human pathology. 1993, Vol 24, Num 4, pp 442-448, issn 0046-8177Article